EMILY CARTER: Open Payments
NPI 1033991229 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,805 in 104 payments from 33 companies in 2025. Trend: 2023 $50 · 2024 $2,169 · 2025 $2,805
Food & beverage: $2,447Education: $359
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $512 |
| Incyte Corporation | 9 | $308 |
| SERVIER PHARMACEUTICALS LLC | 9 | $215 |
| Pharmacosmos Therapeutics Inc. | 7 | $200 |
| Geron Corporation | 3 | $157 |
| BeOne Medicines USA, Inc. | 1 | $146 |
| Novocure Inc. | 2 | $144 |
| Dendreon Pharmaceuticals LLC | 7 | $144 |
| Janssen Biotech, Inc. | 6 | $106 |
| Aveo Pharmaceuticals, Inc. | 2 | $102 |
Products named: ENHERTU, MONOFERRIC, JAKAFI, RYTELO, BRUKINSA, Optune Gio, PROVENGE, Voranigo.
Industry payments across TX — which companies pay providers there.
